Storage and handling
Other information Do not store above 30 o C or 86 o F
No7 Stay Perfect Foundation Sunscreen SPF 15 Vanilla
- Manufacturer
- BCM Cosmetique SAS | The Boots Company PLC
- Effective date
- 2010-12-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:26:37
Label at a glance#
ProductNo7 Stay Perfect Foundation Sunscreen SPF 15 Vanilla 25
Active ingredientOCTINOXATE, TITANIUM DIOXIDE
Label structure16 sections
Contacts and useful links#
Websitewww.boots.com
www.boots.com
www.boots.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose
Octinoxate 5% Sunscreens
Titanium Dioxide 1.6%
OTC - PURPOSE SECTION
Uses
- Provides moderate protection against adverse effects of the sun
- Higher SPF gives more protection
WARNINGS AND PRECAUTIONS SECTION
Warnings
For external use only
When using this product
Keep out of eyes. Rinse with water to remove.
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if rash or irritation develops and lasts
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If swallowed get medical help.
INDICATIONS & USAGE SECTION
Directions
- Use as a normal foundation
- Apply evenly at least 15 minutes before sun exposure
- Reapply as needed
- Not intended for children under the age of 12
- Not intended for protection while sunbathing
STORAGE AND HANDLING SECTION
Other information
Do not store above 30oC or 86oF
INACTIVE INGREDIENT SECTION
Inactive ingredients
Aqua (Water), Cyclopentasiloxane, Talc, Mica, Ethylhexyl stearate, Cyclohexasiloxane, Dimethicone, Silica, Butylene glycol, Cetyl PEG/PPG-10/1 Dimethicone, Disteardimonium hectorite, Hexyl laurate, Polyglyceryl-4 isostearate, Dimethicone copolyol, Magnesium sulfate, Phenoxyethanol, Propylene carbonate, Methylparaben, Sodium ascorbyl phosphate, Sodium PCA, Aluminum stearate, Alumina, Tocopheryl acetate, Propylene glycol, Glycerin, Triethoxycaprylylsilane, Sodium lauroyl lactylate, Isopropyl palmitate, Butylparaben, Ethylparaben, Lecithin, Tetrasodium EDTA, Propylparaben, Isobutylparaben, Ceramide 3, BHT, Ceramide 6 II, Cholesterol, Phytosphingosine, Morus alba leaf extract, Carbomer, Xanthan gum, Ceramide 1, [+/1 (May contain) CI 77891 (Titanium dioxide), CI 77492 (Iron oxides), CI 77491 (Iron oxides), CI 77499 (Iron oxides).
OTC - QUESTIONS SECTION
Questions? 1-866-75-BOOTS
DESCRIPTION SECTION
Staying power...
Discover picture-perfect skin from morning till night, with this stay perfect moisturising foundation. Soft, silky and flattering in any light, it's rub resistant and won't let you down. Fragrance free and easy to blend without blocking your pores.
Ready to face the day...
Shake before use. Dot onto your face and blend smoothly and evenly with your fingers or a sponge, working downwards and outwards from the centre of your face.
Non-pore blocking.
Discover picture-perfect skin from morning till night, with this stay perfect moisturising foundation. Soft, silky and flattering in any light, it's rub resistant and won't let you down. Fragrance free and easy to blend without blocking your pores.
Ready to face the day...
Shake before use. Dot onto your face and blend smoothly and evenly with your fingers or a sponge, working downwards and outwards from the centre of your face.
Non-pore blocking.
INFORMATION FOR PATIENTS SECTION
Mfd in France for BBI NG2 3AA. UK
Dist in the USA by Boots Retail USA Inc Stamford CT 06901
OTC - ACTIVE INGREDIENT SECTION
Bottle label
Active Ingredients:
Octinoxate 5%
Titanium Dioxide 1.6%
DESCRIPTION SECTION
Discover picture-perfect skin from morning till night, with this stay perfect moisturising foundation. Soft, silky and flattering in any light, its rub resistant and won't let you down.
Shake well before use. Blend on smoothly and evenly with your fingers or a sponge.
Shake well before use. Blend on smoothly and evenly with your fingers or a sponge.
Non-pore blocking.
INFORMATION FOR PATIENTS SECTION
Mfd in France for BBI Ltd NG2 3AA. UK
Dist in the USA by Boots Retail USA Inc. Stamford CT 06901
USA: Questions? 1-866-75-BOOTS
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Carton label
No7 Stay Perfect
Perfection Continue
Foundation
Fond de Teint
For a long-lasting flawless finish
Sunscreen SPF 15
Hypo-allergenic
Boots
30ml e 1 US Fl. Oz
Stay Perfect Fdn carton.jpg
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Stay Perfect
Foundation
Sunscreen SPF 15
Hypo-allergenic
Boots
30ml e 1 US Fl. Oz
Stay Perfect Fdn bottle labels.jpg
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61589-1815-1 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c40a-8e05-e053-dbdaa90a074a | Carton and bottle labelling |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61589-1815-1 | No7 Stay Perfect Foundation Sunscreen SPF 15 Vanilla25 | 30 mL in 1 BOTTLE, GLASS | EMULSION | 30 | 1 | |
| 61589-1815-1 | No7 Stay Perfect Foundation Sunscreen SPF 15 Vanilla25 | 1 in 1 CARTON | EMULSION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61589-1815 | NO7 STAY PERFECT FOUNDATION SUNSCREEN SPF 15 VANILLA 25 (OCTINOXATE AND TITANIUM DIOXIDE) EMULSION [BCM COSMETIQUE SAS] | 1 | Legacy NDC, 2 package rows | 20101210_a20cbbeb-6b20-46df-b2c7-e3da5c6be46b.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE, DL- | INACTIVE INGREDIENT | WR1WPI7EW8 | 1 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| ALUMINUM STEARATE | INACTIVE INGREDIENT | U6XF9NP8HM | 1 | |
| ASIAN GINSENG | INACTIVE INGREDIENT | CUQ3A77YXI | 1 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| BUTYLPARABEN | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| CARBOMER HOMOPOLYMER TYPE C | INACTIVE INGREDIENT | 4Q93RCW27E | 1 | |
| CHOLESTEROL | INACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HEXYL LAURATE | INACTIVE INGREDIENT | 4CG9F9W01Q | 1 | |
| ISOBUTYLPARABEN | INACTIVE INGREDIENT | 0QQJ25X58G | 1 | |
| ISOPROPYL PALMITATE | INACTIVE INGREDIENT | 8CRQ2TH63M | 1 | |
| LECITHIN, SOYBEAN | INACTIVE INGREDIENT | 1DI56QDM62 | 1 | |
| MAGNESIUM SULFATE, UNSPECIFIED | INACTIVE INGREDIENT | DE08037SAB | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| OCTYLTRIETHOXYSILANE | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYGLYCERYL-4 ISOSTEARATE | INACTIVE INGREDIENT | 820DPX33S7 | 1 | |
| PROPYLENE CARBONATE | INACTIVE INGREDIENT | 8D08K3S51E | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM ASCORBYL PHOSPHATE | INACTIVE INGREDIENT | 836SJG51DR | 1 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| WHITE MULBERRY | INACTIVE INGREDIENT | MN25R0HH5A | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- No7 Stay Perfect Foundation Sunscreen SPF 15 Vanilla 25
- Octinoxate and Titanium Dioxide
- OCTINOXATE
- TITANIUM DIOXIDE
- WATER
- CYCLOMETHICONE 5
- TALC
- CYCLOMETHICONE 6
- DIMETHICONE
- SILICON DIOXIDE
- BUTYLENE GLYCOL
- HEXYL LAURATE
- POLYGLYCERYL-4 ISOSTEARATE
- MAGNESIUM SULFATE, UNSPECIFIED
- PHENOXYETHANOL
- PROPYLENE CARBONATE
- METHYLPARABEN
- SODIUM ASCORBYL PHOSPHATE
- SODIUM PYRROLIDONE CARBOXYLATE
- ALUMINUM STEARATE
- ALUMINUM OXIDE
- .ALPHA.-TOCOPHEROL ACETATE, DL-
- PROPYLENE GLYCOL
- GLYCERIN
- OCTYLTRIETHOXYSILANE
- ISOPROPYL PALMITATE
- BUTYLPARABEN
- ETHYLPARABEN
- LECITHIN, SOYBEAN
- EDETATE SODIUM
- PROPYLPARABEN
- ISOBUTYLPARABEN
- ASIAN GINSENG
- BUTYLATED HYDROXYTOLUENE
- CHOLESTEROL
- WHITE MULBERRY
- CARBOMER HOMOPOLYMER TYPE C
- XANTHAN GUM
- FERRIC OXIDE YELLOW
- FERRIC OXIDE RED
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 61589-1815 | 61589-1815-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO, SUSPENSION / TOPICAL | 0.15 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / INTRAVENOUS | 5 %w/v | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE / ORAL | 11 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO / TOPICAL | 0.15 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | ENEMA / RECTAL | 150 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | OINTMENT / TOPICAL | 29 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 15 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAMUSCULAR | 6 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | JELLY / NASAL | 140 mg | ||
| CARBOMER HOMOPOLYMER TYPE C | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | CREAM, AUGMENTED / TOPICAL | 20 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | TABLET / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / ORAL | 24 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / ORAL | 1 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | LIQUID / TOPICAL | 0.1 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / OPHTHALMIC | 0.02 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | CREAM / TOPICAL | 0.4 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / NASAL | 14 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | CREAM / VAGINAL | 1 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAVENOUS | 6 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GEL / TOPICAL | 24 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE / ORAL | 3 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / OPHTHALMIC | 2 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GEL, METERED / TOPICAL | 4 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 170 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER / ORAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | 30 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE, LIQUID FILLED / ORAL | 0.1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY, METERED / NASAL | 240 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / RECTAL | 90400 mg | ||
| CARBOMER HOMOPOLYMER TYPE C | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL / TRANSDERMAL | 150 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CREAM / VAGINAL | 3 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CONCENTRATE / ORAL | 2.5 mg/5ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / TOPICAL | 0.75 %w/v | ||
| TALC | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION / INTRAVENOUS | NA | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM, AUGMENTED / TOPICAL | 0.2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / TOPICAL | 5.28 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.8 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET / ORAL | 8 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a7dd249a-39b3-454c-958e-5894d49eab1b | a20cbbeb-6b20-46df-b2c7-e3da5c6be46b | 2010-12-10 | Warnings | a7dd249a-39b3-454c-958e-5894d49eab1b a20cbbeb-6b20-46df-b2c7-e3da5c6be46b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.